PLA2R1 and diabetes mellitus: Chronic cholecystitis led to the formation of antibodies against PLA2R, and the presence of diabetes mellitus with other SLE antibodies that underwent subepithelial deposition led to the activation of the lectin pathway, conformational changes in the structure of PLA2R, and epitope spreading.